Viome Life Sciences acquires Naring Well being and its subsidiaries


Viome Life Sciences, maker of at-home assessments for intestine and immune system well being, introduced it has acquired digital health-and-wellness knowledge firm Naring Well being, together with its subsidiaries DiscernDX and Foodome. 

Viome is break up into two divisions, one promoting client merchandise like microbiome assessments that present weight loss plan suggestions and dietary supplements, and the opposite targeted on figuring out biomarkers for continual ailments to assist with prediction, early detection and precision therapeutics. 

The corporate makes use of AI and a gene expression database to develop home-based assessments, together with a total-body intelligence check for users to acquire meals suggestions and create custom-formulated dietary supplements and probiotics and an oral-health intelligence check, utilizing its VRx My·Biotics Oral Lozenges, that’s focused at evaluating and enhancing one’s oral micro organism.

It additionally provides a Intestine Intelligence Check, obtainable by means of CVS on-line and in-store, to assist one perceive their intestine well being and procure suggestions for probiotic strains and prebiotic fibers.

Naring Well being provides medical and molecular knowledge to information medical choices, whereas DiscernDX is a health-monitoring firm geared toward early illness detection. 

Foodome is an organization that identifies the bioactive compounds in meals and makes use of science to grasp the connection between genetics, weight loss plan and ailments.

Viome will mix the businesses’ sources, together with patents and mental property, to supply extra exact meals and complement suggestions for personalised diet.

“Viome’s acquisition of Naring Well being marks a pivotal second within the evolution of personalised diet and longevity,” Naveen Jain, founder and CEO of Viome, informed MobiHealthNews in an e mail. “We’re poised to revolutionize how people handle their precision dietary wants primarily based on their distinctive biology. Collectively, we’re unlocking extraordinary insights that maintain the important thing to residing more healthy and longer by means of the ability of meals as drugs.”


Viome closed a $86.5 million oversubscribed Series C funding round in August, bringing its complete increase to $175 million. The corporate additionally introduced it launched its Intestine Intelligence Check in 200 CVS areas.

In 2021, the corporate raised $54 million in pre-Series C convertible funding and $56 million in Sequence B funding in 2019. It scored $15 million in August 2017.

The Washington-based firm obtained FDA breakthrough device designation for its mRNA evaluation expertise and AI platform in 2021, which detects early indicators of oral and throat most cancers by means of a consumer’s saliva samples. 

About Author

Leave a Reply

Your email address will not be published. Required fields are marked *